Salix Pharma to restate past seven quarters' results
January 28, 2015 at 17:02 PM EST
Jan 28 (Reuters) - Salix Pharmaceuticals Ltd said it will restate its financial statements for all of 2013 and the first three quarters of 2014 due to errors relating to, among others, the timing of revenue recognition.
